Monday, April 27, 2020 8:16:44 AM
But the company’s initial forecast of providing 50,000 tests a day, starting soon, may need to await further validation. A researcher at the Cleveland Clinic, Gary Procop, MD, tested five products on 239 patient samples known to be positive for COVID-19. Abbott’s test missed 15 percent.
https://geneticliteracyproject.org/2020/04/27/at-home-coronavirus-test-how-crispr-could-change-the-way-we-search-for-covid-19/
I guess the standards are lower in Europe than in the U.S.. Wondering how ABT is going to pivot from this tech & procedure to something more reliable.
Recent ABT News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:04:06 PM
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test • PR Newswire (US) • 04/17/2026 07:30:00 PM
- Abbott Shares Slip on Weaker Q2 Outlook Despite In-Line Q1 Results • IH Market News • 04/16/2026 02:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 11:36:25 AM
- Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences • PR Newswire (US) • 04/16/2026 11:30:00 AM
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health • PR Newswire (US) • 04/09/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:24:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:15:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:07:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:00:50 PM
- Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform • PR Newswire (US) • 03/30/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/26/2026 07:05:51 PM
- Abbott hosts conference call for first-quarter earnings • PR Newswire (US) • 03/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:56:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:46:39 PM
- John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening • PR Newswire (US) • 03/24/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/23/2026 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:54:17 PM
- Abbott completes acquisition of Exact Sciences • PR Newswire (US) • 03/23/2026 12:50:00 PM
- Abbott acquisition of Exact Sciences set to close on March 23, 2026 • PR Newswire (US) • 03/20/2026 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/13/2026 08:01:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/13/2026 08:00:23 PM
- Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management • PR Newswire (US) • 03/12/2026 12:00:00 PM
